Europe PMCopen access
A novel therapeutic regimen based on the constrained-disorder principles may improve the response to dimethyl fumarate in multiple sclerosis: Findings from an exploratory feasibility open-label clinical trial
Artificial intelligence, Variability, Multiple sclerosis, Dimethyl Fumarate, Non-linearity
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 983616
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.